Loading…
Provides a technology-enabled practice management platform that helps independent physician groups operate and take on value-based care.
Provides a technology-enabled practice management platform that helps independent physician groups operate and take on value-based care.
Takes a fee tied to what its affiliated practices collect, in return for running billing, technology and back-office work, and shares in the savings when it holds patients' care costs below targets set by Medicare and insurers. The second stream grows as more doctors accept contracts that put them at financial risk for outcomes.
Moat: narrow (switching costs, data, installed base). Deep integration into physician workflows and payer contracts creates switching costs versus building capabilities in-house.
Headquarters: Arlington, Virginia, United States · Founded: 2007 · Employees: 1,226
Size Privia Health (PRVA) is a United States Financials company (Life/Health Insurance) with a market value of $3.12B, the 1519th largest of 3,117 United States companies the cockpit tracks. Shares closed at $24.42 on 6 Nov 2026.
Performance Over six months the shares gained 5.9%, against +3.5% for the median peer and -1.1% for the United States market (cap-weighted) — 10th highest of 21 in its peer set.
Growth Revenue grew 24.1% over the last twelve months (peer median +17.3%); the operating margin is 1.9% (peer median 7.3%).
Valuation It trades at 3.94× book value against a peer median of 2.17× (6th most expensive of 21).
Price implies The share price implies a return on equity of about 25.4%; Privia Health delivers 3.8%, so the price asks more than the business earns today.
Short interest Short interest is 3.9% of the free float (15 Oct 2026).
Next results Next results expected around 2 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $2.36B | $2.12B | $1.74B | $1.66B | $1.36B |
| Revenue growth | — | +22% | +5% | +22% | — |
| Gross profit | $224M | $200M | $170M | $155M | $130M |
| EBITDA | $56.9M | $44.1M | $24.2M | $27.2M | -$14.6M |
| Net income | $28.1M | $22.9M | $14.4M | $23.1M | -$8.59M |
| Free cash flow | $130M | $162M | $104M | $80.7M | $47.1M |
| Capital expenditure | $1.26M | $1.20M | $5.02M | $113,000 | $104,000 |
| Total debt | $8.73M | $9.53M | $5.59M | $8.29M | $11.5M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | ROE | Price / book | Implied ROE |
|---|---|---|---|---|---|---|
| Privia Health PRVA | $3.12B | +6% | +24% | 4% | 3.94× | 25.4% |
| agilon health AGL | $1.90B | +109% | 0% | -79% | 8.36× | 144.0% |
| Evolent Health EVH | $518M | +10% | -4% | -79% | 1.35× | 12.5% |
| Astrana Health ASTH | $1.71B | -12% | +59% | 5% | 2.05× | 18.9% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | PRVA | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +20.9% | -0.3% | 2nd highest of 21 |
| 6-month return | +5.9% | +3.5% | 10th highest of 21 |
| Return on equity | 3.8% | 10.6% | 3rd lowest of 21 |
| Price / book | 3.94× | 2.17× | 6th most expensive of 21 |
| Trailing P/E | 113.3× | 15.9× | 2nd most expensive of 20 |
| ROE the price implies | 25.4% | 16.5% | 8th most demanding of 21 |
| ROE delivered | 3.8% | 10.6% | 3rd lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | ROE | Price / book | Implied ROE | Delivered ROE |
|---|---|---|---|---|---|---|---|---|
| Privia Health PRVA | United States | $3.12B | +6% | +24% | 4% | 3.94× | 25.4% | 3.8% |
| COFCO Capital 002423.SZ | China | $3.15B | -11% | -31% | 6% | 0.85× | 6.2% | 5.6% |
| Star Health & Allied Insurance STARHEALTH.NS | India | $3.52B | +9% | +21% | 12% | 3.19× | 47.7% | 11.7% |
| Clover Health Investments CLOV | United States | $2.56B | +54% | +54% | -5% | 6.32× | 94.7% | -5.1% |
| Brighthouse Financial BHF | United States | $2.45B | -31% | +3% | 14% | 0.37× | 5.2% | 13.6% |
| Hanwha Life 088350.KS | South Korea | $2.16B | -20% | +18% | 8% | 0.22× | 3.8% | 7.7% |
| Max Financial Services MFSL.NS | India | $4.68B | -25% | +18% | 3% | 7.71× | 78.7% | 3.3% |
| E-L Financial ELF.TO | Canada | $4.74B | +10% | +32% | 20% | 0.68× | 6.4% | 20.2% |
| Mirae Asset Life Insurance 085620.KS | South Korea | $1.78B | +17% | +22% | 5% | 1.05× | 5.6% | 5.2% |
| Challenger CGF.AX | Australia | $5.59B | +36% | -25% | 13% | 2.01× | 15.8% | 13.3% |
| Nuernberger Beteiligungs NBG6.DE | Germany | $1.58B | +1% | -1% | 5% | 1.58× | 6.0% | 5.1% |
| Niva Bupa Health Insurance NIVABUPA.NS | India | $1.49B | -5% | +58% | 14% | 3.66× | 33.1% | 13.9% |
| ICICI Life Insurance ICICILIFE.NS | India | $6.77B | -22% | -8% | 13% | 4.67× | 65.0% | 12.6% |
| St. James's Place STJ.L | United Kingdom | $7.48B | -3% | +164% | 38% | 3.64× | 43.3% | 38.4% |
| Canara HSBC Life Insurance CANHLIFE.NS | India | $1.23B | -14% | +17% | 8% | 7.08× | 48.0% | 8.2% |
| Jackson Financial Incorporation JXN | United States | $8.70B | +17% | +34% | 9% | 1.10× | 12.5% | 9.5% |
| Voya Financial VOYA | United States | $8.91B | +21% | -3% | 14% | 2.34× | 17.2% | 14.3% |
| Primerica PRI | United States | $8.94B | +6% | +8% | 33% | 3.56× | 24.9% | 32.9% |
| Yunfeng Financial 0376.HK | Hong Kong | $999M | -30% | +21% | 7% | 0.60× | 7.8% | 6.7% |
| Medibank Private MPL.AX | Australia | $9.94B | +14% | +9% | 27% | 5.90× | 23.8% | 26.8% |
| JAPAN POST INSURANCE 7181.T | Japan | $11.2B | +8% | -6% | 4% | 0.38× | 2.9% | 4.2% |